Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Solutions Erroneously Refiles 2000 IPO Forms: May 24, 2005 (rev. 1)

This article has been updated and corrected from an initial version, which cited a Reuters report that Genomic Solutions had filed for an IPO today.

 

NEW YORK, May 24 (GenomeWeb News) - Genomic Solutions, a subsidiary of Harvard Bioscience, erroneously refiled its initial public offering documents from 2000 early yesterday.

 

The registration forms were later removed from the SEC's web site, but not before several wire services, inlcuding GenomeWeb News, reported that the company was filing for an IPO of up to $100 million in common stock.

 

A Genomic Solutions spokesman told Dow Jones earlier today that the forms it released were an "erroneous reissue."

 

Neither Genomic Solutions nor Harvard Bioscience returned GenomeWeb News' calls for comment.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.